[
    [
        {
            "time": "",
            "original_text": "迈瑞医疗董事长李西廷：要推动医疗生产企业实现产业链自主可控",
            "features": {
                "keywords": [
                    "迈瑞医疗",
                    "董事长",
                    "产业链",
                    "自主可控"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "制造业"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "迈瑞医疗董事长李西廷：要推动医疗生产企业实现产业链自主可控",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "迈瑞医疗(300760.SZ)：10亿捐赠是徐航先生的个人行为",
            "features": {
                "keywords": [
                    "迈瑞医疗",
                    "捐赠",
                    "徐航",
                    "个人行为"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "迈瑞医疗(300760.SZ)：10亿捐赠是徐航先生的个人行为",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "【中原策略】2020基金年报分析：公募年报持仓一览：加仓周期制造，疫情直接受益板块渐趋退出",
            "features": {
                "keywords": [
                    "基金年报",
                    "加仓",
                    "周期制造",
                    "疫情受益",
                    "退出"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "制造业",
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "【中原策略】2020基金年报分析：公募年报持仓一览：加仓周期制造，疫情直接受益板块渐趋退出",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "国信证券-医药行业一周观察：关注财报季投资机会，第四批药品集采即将落地执行【行业研究】",
            "features": {
                "keywords": [
                    "国信证券",
                    "医药行业",
                    "财报季",
                    "药品集采",
                    "投资机会"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "国信证券-医药行业一周观察：关注财报季投资机会，第四批药品集采即将落地执行【行业研究】",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "19家药企被处罚，4700亿龙头在列，更有全球医药巨头",
            "features": {
                "keywords": [
                    "药企",
                    "处罚",
                    "龙头",
                    "全球医药巨头"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "19家药企被处罚，4700亿龙头在列，更有全球医药巨头",
                "Correlation": 6,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 9,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        }
    ]
]